Abstract:

Ranitidine hydrochloride being one of the most commonly used drugs and its use is well provident. Furthermore, anaphylactic reactions are rarely observed with the use of ranitidine hydrochloride. Hypersensitivity reactions are usually common in clinical practice but adverse reaction to intravenous ranitidine is very rare. Here we report a case, where the patient developed an anaphylactic reaction with a single dose of intravenous ranitidine in cholangiocarcinoma patient. This report highlights the importance of recognition of the serious adverse events that might follow and the need for cautiousness with the use of ranitidine in the future prospects.

IJOPP uses reference linking service using Digital Object Identifiers (DOI) by Crossref. Articles from the year 2014 are being assigned DOIs for its permanent URLs

Indian Journal of Pharmacy Practice is an official Publication of Association of Pharmaceutical Teachers of India, Bangalore. The journals and its contents are licensed under a Creative Commons Attribution-Non Commercial-No Derivs 4.0 License. Permissions beyond the scope of this license may be available with editor@ijopp.org